Ian El-Mokadem Buys 500 Shares of Diploma PLC (LON:DPLM) Stock

Diploma PLC (LON:DPLM) insider Ian El-Mokadem purchased 500 shares of the company’s stock in a transaction dated Monday, March 24th. The shares were bought at an average cost of GBX 3,948 ($51.01) per share, for a total transaction of £19,740 ($25,507.17).

Diploma Trading Down 0.1 %

LON DPLM traded down GBX 2 ($0.03) during trading on Tuesday, hitting GBX 3,980 ($51.43). The stock had a trading volume of 250,617 shares, compared to its average volume of 529,895. The stock has a market capitalization of £5.31 billion, a price-to-earnings ratio of 45.75, a P/E/G ratio of 2.82 and a beta of 0.75. The stock has a 50 day simple moving average of GBX 4,388.20 and a 200 day simple moving average of GBX 4,381.82. Diploma PLC has a one year low of GBX 3,372 ($43.57) and a one year high of GBX 4,808 ($62.13). The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17.

Diploma Increases Dividend

The business also recently announced a dividend, which was paid on Friday, January 31st. Shareholders of record on Thursday, January 16th were paid a GBX 42 ($0.54) dividend. This is an increase from Diploma’s previous dividend of $17.30. This represents a yield of 0.93%. The ex-dividend date was Thursday, January 16th. Diploma’s dividend payout ratio is currently 65.52%.

Wall Street Analyst Weigh In

Separately, JPMorgan Chase & Co. boosted their target price on shares of Diploma from GBX 4,370 ($56.47) to GBX 4,420 ($57.11) and gave the company a “neutral” rating in a research note on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of GBX 4,567.50 ($59.02).

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.